Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development.

Sayers S, Ulysse G, Xiang Z, He Y.

J Biomed Biotechnol. 2012;2012:831486. doi: 10.1155/2012/831486. Epub 2012 Mar 13.

2.

Protegen: a web-based protective antigen database and analysis system.

Yang B, Sayers S, Xiang Z, He Y.

Nucleic Acids Res. 2011 Jan;39(Database issue):D1073-8. doi: 10.1093/nar/gkq944. Epub 2010 Oct 19.

3.

Updates on the web-based VIOLIN vaccine database and analysis system.

He Y, Racz R, Sayers S, Lin Y, Todd T, Hur J, Li X, Patel M, Zhao B, Chung M, Ostrow J, Sylora A, Dungarani P, Ulysse G, Kochhar K, Vidri B, Strait K, Jourdian GW, Xiang Z.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1124-32. doi: 10.1093/nar/gkt1133. Epub 2013 Nov 19.

4.

DNAVaxDB: the first web-based DNA vaccine database and its data analysis.

Racz R, Li X, Patel M, Xiang Z, He Y.

BMC Bioinformatics. 2014;15 Suppl 4:S2. doi: 10.1186/1471-2105-15-S4-S2. Epub 2014 Mar 19.

5.

Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN.

He Y, Xiang Z.

Immunome Res. 2010 Sep 27;6 Suppl 1:S5. doi: 10.1186/1745-7580-6-S1-S5.

6.

VIOLIN: vaccine investigation and online information network.

Xiang Z, Todd T, Ku KP, Kovacic BL, Larson CB, Chen F, Hodges AP, Tian Y, Olenzek EA, Zhao B, Colby LA, Rush HG, Gilsdorf JR, Jourdian GW, He Y.

Nucleic Acids Res. 2008 Jan;36(Database issue):D923-8. Epub 2007 Nov 19.

7.

Vaxvec: The first web-based recombinant vaccine vector database and its data analysis.

Deng S, Martin C, Patil R, Zhu F, Zhao B, Xiang Z, He Y.

Vaccine. 2015 Nov 27;33(48):6938-46. doi: 10.1016/j.vaccine.2015.07.113. Epub 2015 Sep 25.

8.

Databases and in silico tools for vaccine design.

He Y, Xiang Z.

Methods Mol Biol. 2013;993:115-27. doi: 10.1007/978-1-62703-342-8_8. Review.

PMID:
23568467
9.
10.

Trends in vaccine adjuvants.

Schijns VE, Lavelle EC.

Expert Rev Vaccines. 2011 Apr;10(4):539-50. doi: 10.1586/erv.11.21. Review.

PMID:
21506650
11.

New developments in vaccine research--unveiling the secret of vaccine adjuvants.

de Veer M, Meeusen E.

Discov Med. 2011 Sep;12(64):195-204. Review.

13.

The development and use of vaccine adjuvants.

Edelman R.

Mol Biotechnol. 2002 Jun;21(2):129-48. Review.

PMID:
12059113
14.

Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.

Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G.

Vaccine. 2013 Jul 18;31(33):3327-32. doi: 10.1016/j.vaccine.2013.05.078. Epub 2013 Jun 2.

PMID:
23735678
15.

Adjuvants in perspective.

Vogel FR.

Dev Biol Stand. 1998;92:241-8. Review.

PMID:
9554280
16.

Vaccine adjuvants: scientific challenges and strategic initiatives.

Harandi AM, Davies G, Olesen OF.

Expert Rev Vaccines. 2009 Mar;8(3):293-8. doi: 10.1586/14760584.8.3.293. Review.

PMID:
19249971
17.

Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.

Hur J, Xiang Z, Feldman EL, He Y.

BMC Immunol. 2011 Aug 26;12:49. doi: 10.1186/1471-2172-12-49.

18.

Recent developments in adjuvants for vaccines against infectious diseases.

O'Hagan DT, MacKichan ML, Singh M.

Biomol Eng. 2001 Oct 15;18(3):69-85. Review.

PMID:
11566599
19.

Recent advances of vaccine adjuvants for infectious diseases.

Lee S, Nguyen MT.

Immune Netw. 2015 Apr;15(2):51-7. doi: 10.4110/in.2015.15.2.51. Epub 2015 Apr 23. Review.

20.

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.

Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW.

Int J Pharm. 2008 Dec 8;364(2):272-80. doi: 10.1016/j.ijpharm.2008.04.036. Epub 2008 Apr 30. Review.

PMID:
18555624

Supplemental Content

Support Center